138 related articles for article (PubMed ID: 16359125)
41. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines.
Anderson EC; Masters RC; Mowat GN
Res Vet Sci; 1971 Jul; 12(4):342-50. PubMed ID: 5558541
[No Abstract] [Full Text] [Related]
42. Effect of the sow vaccination regimen on the decay rate of maternally derived foot-and-mouth disease antibodies in piglets.
Francis MJ; Black L
Res Vet Sci; 1984 Jul; 37(1):72-6. PubMed ID: 6089285
[TBL] [Abstract][Full Text] [Related]
43. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines.
Cox SJ; Aggarwal N; Statham RJ; Barnett PV
Vaccine; 2003 Mar; 21(13-14):1336-47. PubMed ID: 12615428
[TBL] [Abstract][Full Text] [Related]
44. Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs.
Rigden RC; Carrasco CP; Barnett PV; Summerfield A; McCullough KC
Vaccine; 2003 Mar; 21(13-14):1466-77. PubMed ID: 12615443
[TBL] [Abstract][Full Text] [Related]
45. [Immunization of pigs against foot-and-mouth disease with tissue culture virus--saponin vaccine].
Schneider B; Bengelsdorf HJ
Dtsch Tierarztl Wochenschr (1946); 1963 Sep; 70(17):482-5. PubMed ID: 5896740
[No Abstract] [Full Text] [Related]
46. The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccination.
Black L; Francis MJ; Rweyemamu MM; Umebara O; Boge A
J Biol Stand; 1984 Oct; 12(4):379-89. PubMed ID: 6098583
[TBL] [Abstract][Full Text] [Related]
47. [Round table discussion about foot and mouth disease prevention and control. The goals and differences of opinion on how to get there].
Vaarten J
Tijdschr Diergeneeskd; 2001 Sep; 126(18):608-10. PubMed ID: 11596536
[No Abstract] [Full Text] [Related]
48. Serological study of type A Indian foot-and-mouth disease virus isolates.
Meer Azad H; Srinivasan VA; Crowther JR
Acta Virol; 1995 Sep; 39(4):193-6. PubMed ID: 8825299
[TBL] [Abstract][Full Text] [Related]
49. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach.
Barnett PV; Statham RJ; Vosloo W; Haydon DT
Vaccine; 2003 Jul; 21(23):3240-8. PubMed ID: 12804854
[TBL] [Abstract][Full Text] [Related]
50. [Vaccination of pigs with a DEAE dextran containing bivalent foot and mouth disease vaccine].
Bauer K; Wittmann G; Geilhausen H; Irion E
Berl Munch Tierarztl Wochenschr; 1974 May; 87(9):170-3. PubMed ID: 4831340
[No Abstract] [Full Text] [Related]
51. Regulatory considerations for emergency use of vaccines in the European Union.
Pastoret PP; Mackay D
Dev Biol (Basel); 2003; 114():53-8. PubMed ID: 14677676
[TBL] [Abstract][Full Text] [Related]
52. [Practical experiences in the immunization of pigs against foot-and-mouth disease].
Kamphans S; Schneider B
Dtsch Tierarztl Wochenschr (1946); 1963 Jan; 70(1):1-3. PubMed ID: 5896721
[No Abstract] [Full Text] [Related]
53. [A hitherto unknown reaction pattern in vertebrate cells (RiV). 2. The protective effect of RiV particle preparations against foot-and-mouth disease in guinea pigs].
Solisch P; Nöckler A; Schäfer D; Riebe R; Holl U; Schirrmeier H; Kretzschmar C; Wazel W; Dietz G; Sulk J
Zentralbl Allg Pathol; 1986; 131(6):563-8. PubMed ID: 3020838
[TBL] [Abstract][Full Text] [Related]
54. [Thermostabile inhibitor against foot-and-mouth disease virus in pig serum. IV. Relationship to antibody production after inoculation].
Bögel K; Wittmann G; Eissner G
Zentralbl Veterinarmed B; 1967 Oct; 14(6):520-36. PubMed ID: 5628220
[No Abstract] [Full Text] [Related]
55. [The role of passive immunization of piglets against foot-and-mouth disease].
Sidorov IV
Veterinariia; 1974 Sep; (9):40-1. PubMed ID: 4466043
[No Abstract] [Full Text] [Related]
56. [Immunogenic properties of an experimental vaccine against foot-and-mouth disease].
Siusiukin AA; Kravets IK; Tsvetkova NE; Pavlov VG
Veterinariia; 1971 May; 5():40-2. PubMed ID: 5158658
[No Abstract] [Full Text] [Related]
57. [Study of the immunity in sheep inoculated with aluminum hydroxide formolized vaccine against foot-and-mouth disease].
Irza LA
Veterinariia; 1973 Sep; 9():38-40. PubMed ID: 4783613
[No Abstract] [Full Text] [Related]
58. Rapidity of specific antibody-antigen interactions.
Scicluna LA; McCullough KC
Scand J Immunol; 1999 Aug; 50(2):167-76. PubMed ID: 10447921
[TBL] [Abstract][Full Text] [Related]
59. [Indirect complement fixation with mouse sera after inoculation with monovalent foot-and-mouth vaccine].
Traub E; Bechmann G
Zentralbl Veterinarmed B; 1969; 16(3):240-52. PubMed ID: 5794773
[No Abstract] [Full Text] [Related]
60. [Studies on the protective inoculation of 6- to 8-week-old piglets with ethylethylenimine (EEI) diethylaminoethyl-dextran (DEAE-D) vaccines against foot-and-mouth disease caused by virus type O1].
Wittmann G; Bauer K; Mussgay M
Zentralbl Veterinarmed B; 1971 Mar; 18(2):135-46. PubMed ID: 5573992
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
